Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage

Not yet recruiting

Phase 2 Results N/A

Summary of Purpose

Many people who have undergone subarachnoid hemorrhage from an aneurysm (an artery of a vein in the brain) struggle with a pronounced fatigue as well as a number of other sequelae such as impaired concentration, memory deficits and emotional problems. Exhaustion is often permanent and can lead to a significant worsening of quality of life and be the cause of disability. This condition does not only have major...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 July 2017.

1 Sep 2017 28 Jun 2017 1 Nov 2019 1 Nov 2019 1 Jul 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts